Groowe Groowe / Newsroom / JSPR
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

JSPR News

Jasper Therapeutics, Inc. Common Stock

Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

globenewswire.com
JSPR

Juniper Square Acquires Sightglass to Bolster AI Capabilities for Private Markets Investor Relations

prnewswire.com
JSPR

Form 8-K

sec.gov
JSPR JSPRW

Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

globenewswire.com
JSPR

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Jasper Therapeutics, Inc. (JSPR) and Encourages Shareholders to Learn More About the Investigation

accessnewswire.com
JSPR

Jasper Therapeutics, Inc. (JSPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

accessnewswire.com
JSPR

Bronstein, Gewirtz & Grossman, LLC Encourages Jasper Therapeutics, Inc. (JSPR) Shareholders to Inquire about Securities Investigation

accessnewswire.com
JSPR

Bronstein, Gewirtz & Grossman, LLC Is Investigating Jasper Therapeutics, Inc. (JSPR) And Encourages Shareholders to Connect

accessnewswire.com
JSPR

Bronstein, Gewirtz & Grossman, LLC Encourages Jasper Therapeutics, Inc. (JSPR) Stockholders to Inquire about Securities Investigation

accessnewswire.com
JSPR

Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference

globenewswire.com
JSPR